Daiichi Sankyo Profile

USD 0.1  0.24%

Daiichi Sankyo Summary

Daiichi Sankyo Company Limited (DSNKY) is traded on OTC Market in USA. It is located in 3-5-1, Nihonbashi-honcho and employs 14,446 people. The company currently falls under 'Large-Cap' category with current market capitalization of 26.82 B. Daiichi Sankyo Company Limited has 663.36 M outstanding shares. DAIICHI SANKYO has accumulated about 3.25 B in cash with 984.73 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.01.
Check Daiichi Sankyo Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 41.28HorizonTargetOdds Above 41.28
98.10%30 days 41.28 1.85%
Based on normal probability distribution, the odds of Daiichi Sankyo to move above current price in 30 days from now is about 1.85% (This Daiichi Sankyo Company Limited probability density function shows the probability of Daiichi Sankyo Stock to fall within a particular range of prices over 30 days) .

Daiichi Sankyo Limited Risk Profiles

Key Fundamentals

Daiichi Sankyo Against Markets

Current Ratings

Daiichi Sankyo 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Daiichi Sankyo Company Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Daiichi Sankyo Company, Limited researches, develops, manufactures, imports, and markets pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo is traded on OTC Market in USA. more
NameDaiichi Sankyo Company Limited
CEOJoji NakayamaView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address3-5-1, Nihonbashi-honcho
ExchangeOTC Market
Phone81 3 6225 1111
CurrencyUSD - US Dollar

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Alpha Finder

Daiichi Sankyo Corporate Directors

Glenn Gormley Senior Managing Executive Officer, Chief Director of Research & Development
Masahiko Ohtsuki Executive Officer, Senior Director of Research in Main Research & Development Unit
Takeshi Ogita Senior Managing Executive Officer, Chief Director of General Affairs and Human Resources, Chief Director of Vaccine Business in Japan Company, Director
Additionally see Investing Opportunities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.